Home

Modern Diagnostic & Research Centre Ltd 52 Week High

Image

Modern Diagnostic & Research Centre Ltd

NSE: MDRC

YEARHIGH

₹ 100

Last updated on: Jan 13, 2026

Key Highlights

  • The 52 Week HIGH of Modern Diagnostic & Research Centre Ltd is ₹ 100 as of 13 Jan 26 .

Company Fundamentals for Modern Diagnostic & Research Centre Ltd

Market Price of Modern Diagnostic & Research Centre Ltd

1M

1Y

3Y

5Y

Monitoring Modern Diagnostic & Research Centre Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
13 Jan 202687.96
12 Jan 202692.57
09 Jan 202693.63
08 Jan 202691.19
07 Jan 202694.99

Asset Value vs Market Value of Modern Diagnostic & Research Centre Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Historical Revenue of Modern Diagnostic & Research Centre Ltd

No data available

* All values are in crore

Historical Net Profit of Modern Diagnostic & Research Centre Ltd

No data available

* All values are in crore

Modern Diagnostic & Research Centre Ltd News Hub

Shares of Modern Diagnostic & Research Centre lists in MT group

The equity shares of Modern Diagnostic & Research Centre (Scrip Code: 544673) are listed and admitte

Read more

07 Jan 26

BSE SME Modern Diagnostic and Research Centre's IPO ends with 350.49 times subscription

The initial public offer (IPO) of Modern Diagnostic and Research Centre received bids for 1,02,95,90

Read more

07 Jan 26

BSE SME Modern Diagnostic & Research Centre begins its market journey with a steady heartbeat

The scrip was listed at Rs 99.50, a premium of 10.56% compared with the initial public offer (IPO) p

Read more

07 Jan 26

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of null

What is the significance of Modern Diagnostic & Research Centre Ltd reaching its 52-week high?

Modern Diagnostic & Research Centre Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Modern Diagnostic & Research Centre Ltd 52-week high?

Investors monitor Modern Diagnostic & Research Centre Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Modern Diagnostic & Research Centre Ltd a good buy when it hits its 52-week high?

Whether Modern Diagnostic & Research Centre Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Modern Diagnostic & Research Centre Ltd fundamentals.

What should I consider before investing in Modern Diagnostic & Research Centre Ltd at its 52-week high?

Before investing in Modern Diagnostic & Research Centre Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Modern Diagnostic & Research Centre Ltd stock price continue to rise after reaching its 52-week high?

Modern Diagnostic & Research Centre Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions